Results 1 to 10 of about 15,634 (149)
Serum Carbohydrate Antigen 199 as a Biomarker for Evaluating Patients with Choledocholithiasis [PDF]
Gastroenterology Research and Practice, 2020 Aims. Choledocholithiasis is a common and yet potentially debilitating disease of the biliary tract. While certain patients with this disease remain largely asymptomatic or experience mild discomfort, in several cases, patient can suffer biliary ...
Wang Gu, Zhong Tong
doaj +2 more sources
Canadian Journal of Gastroenterology, 2001 Carbohydrate antigen 19-9 is a well known marker for pancreatic adenocarcinoma. However, its limitation is its nonspecificity, because elevated levels may be encountered in other gastrointestinal disorders, both benign and malignant.
Michal Soudack +2 more
doaj +2 more sources
The International Journal of Biological Markers, 2009 Background The aim of this longitudinal study was to try and improve the specificity of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in monitoring tumor recurrence in patients with resectable gastric adenocarcinoma by setting ...
Miao-Zhen Qiu +9 more
doaj +2 more sources
Correlation between carbohydrate antigen 199 and glycemic control in patients with type 2 diabetes mellitus [PDF]
Chinese Medical Journal, 2019 Su-Qing Bao +3 more
doaj +2 more sources
Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma [PDF]
Iranian Journal of Medical Sciences, 2023 Background: Pancreatic cancer is a malignancy with high mortality due to the difficulties in early detection. We investigated and compared the diagnostic and prognostic performance of several blood biomarkers, including microRNA-25 (miR-25), carbohydrate
Yan Gong +5 more
doaj +1 more source
World Journal of Surgical Oncology, 2022 Background The overall survival of patients with pancreatic cancer is extremely low. Despite multiple large-scale studies, identification of predictors of patient survival remains challenging.
Qi Li +5 more
doaj +1 more source
Frontiers in Oncology, 2021 BackgroundAlthough carbohydrate antigen 19-9 (CA19-9) is an established prognostic marker for intrahepatic cholangiocarcinoma (ICC) patients, the significance of elevated preoperative CA19-9 that normalized after resection remains unknown.
Hui Li +9 more
doaj +1 more source
Frontiers in Chemistry, 2021 Lanthanide-doped upconversion nanoparticles (UCNPs) have attracted considerable attention in detection of biological analytes and bioimaging owing to their superior optical properties, including high photochemical stability, sharp emission bandwidth ...
Chaohui Zhou +3 more
doaj +1 more source
World Journal of Surgical Oncology, 2022 Background Intraductal papillary mucinous neoplasms (IPMNs) are characterized by their abundant mucin production and malignant potential. IPMNs of the pancreas are mainly managed according to their radiographic indications, but this approach lacks ...
Yunzhen Qian +12 more
doaj +1 more source
High Carbohydrate Antigen 19-9 Levels Indicate Poor Prognosis of Upper Tract Urothelial Carcinoma
Frontiers in Oncology, 2022 Upper tract urothelial carcinoma (UTUC) occurs in urothelial cells from the kidney and the ureters. Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker for pancreatic and gastrointestinal cancers, and its high levels are associated with poor prognosis ...
Seung-hwan Jeong +11 more
doaj +1 more source